FIELD: pharmacology and medicine.
SUBSTANCE: invention can be used in the field of pharmacology and medicine, in particular phthisiology, and relates to a new use of (5-(methoxycarbonyl)-[1,1'-biphenyl]-3-yl)-L-proline as an agent with anti-tuberculosis activity.
EFFECT: anti-tuberculosis activity drug creation.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUBERCULOSIS AGENT BASED ON 4'-HYDROXY-1'-(2-HYDROXYPHENYL)-3'-ACYL-SPIRO[BENZO[b][1,4]THIAZINE-2,2'-PYRROLE]-3,5'(1 'H,4H)-DIONES | 2023 |
|
RU2806097C1 |
ANTITUBERCULOSIS AGENT BASED ON (Z)-9-AROYL-8-HYDROXY-6-(2-HYDROXYPHENYL)-2-(((E)-PYRIDIN-3-YLMETHYLENE)HYDRAZONO)-1-THIA-3,6-DIAZOSPIRO[4.4]NON-8-ENE-4,7-DIONES | 2023 |
|
RU2808987C1 |
SILVER SALTS OF 1-ARYL-4,4,4-TRIFLUOROBUTANE-1,3-DIONES, EXHIBITING TUBERCULOSTATIC ACTIVITY | 2023 |
|
RU2817114C1 |
APPLICATION OF 1-BENZOYL-5,5-DIMETHYL-5,6-DIHYDROPYRROLO[2,1-A]ISOQUINOLINE-2,3-DIONE AS AN ANTITUBERCULOUS AGENT | 2022 |
|
RU2783286C1 |
USE OF 9-AROYL-8-HYDROXY-6-(2-HYDROXYETHYL)-1,3,6-TRIAZASPIRO[4,4]NON-8-EN-2,4,7-TRIONES AS ANTITUBERCULOUS AGENTS | 2023 |
|
RU2798423C1 |
USE OF (5Z)-2-AMINO-5-(1-BROM-2-OXO-2-PHENYLETHYLIDENE)-4-OXO-1H-4,5-DIHYDROFURAN-3-CARBOXIC ACID ETHER AS A MEDICINAL AGENT WITH TUBERCULOSTATIC ACTIVITY | 2022 |
|
RU2799759C1 |
APPLICATION OF 2-AMINO-5-BROMO-5-(1-BROM-2-OXO-2-PHENYLETHYLIDENE)-4-OXO-1Н-4,5-DIHYDROFURAN-3-CARBOXIC ACID ETHYL AS A MEDICINE WITH TUBERCULOSTATIC ACTIVITY | 2023 |
|
RU2803601C1 |
USE OF (E)-(4-BROMOPHENYL)(6-(2-HYDROXYPHENYL)-2-IMINIO-4,7,8-TRIOXO-1,3-DIPHENYL-1,3,6-TRIAZASPIRO[4.4]NONANE-9 -YLIDENE)METHANOATE AS AGENT WITH ANTI-TUBERCULOSIS ACTIVITY | 2023 |
|
RU2810196C1 |
1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PROPYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2824817C1 |
1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PHENYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2824815C1 |
Authors
Dates
2022-12-05—Published
2022-02-28—Filed